PSMD11 and neoplasm: Collectively, our mechanistic investigations and clinical data analyses establish that PSMD11 and PSMD14, as critical regulatory subunits of the ubiquitin-proteasome system (UPS), drive oncogenic progression through targeted degradation of tumor-suppressive proteins and stabilization of oncoproteins.